That 5.33 million shares were offered for the 1.46 million allotment sought by Elron explains the sudden drop from mid $16s to $15. some weeks ago. Clearly, some knew then of the over subscription.
As the air clears, frozen shares return to their owners minus those taken, will pps rise or fall? I say UP as clarity encourages investment and GIVN is a winning biotech - we'll see.